Horses infected with equine infectious anemia virus (EIAV) have recurrent episodes of viremia which are eventually controlled, but the immune mechanisms have not been identified. Antibodies were detected to the surface of EIAV-infected cells within 1 month postinfection and remained for at least 3.5 years postinfection. These antibodies recognized cell surface-exposed envelope (Env) glycoproteins, but could not mediate antibody dependent cellular cytotoxicity (ADCC) using EIAV-WSU5-infected equine kidney (EK) cells as targets and peripheral blood mononuclear cells (PBMC) or polymorphonuclear cells (PMN) as effector cells. Furthermore, purified IgG antibodies from horses infected with either EIAV-WSU5 or EIAV-Wyo did not mediate ADCC of infected target cells. Armed effector cells could not be detected in infected horse blood nor could effector cells be prearmed by incubation with serum antibodies to cell surface antigens. The use of EIAV-WSU5-infected equine macrophages as target cells did not result in ADCC. In contrast, serum antibody from EHV-1 vaccinated horses and PBMC or PMN as effector cells caused ADCC of EHV-1-infected EK cells. These results indicate that ADCC is not involved in the control of EIAV in carrier horses. ᭧ 1997 Academic Press
INTRODUCTION roconversion occurred (Rushlow et al., 1990) .
EIAV is a lentivirus of horses that causes recurrent
The presence of unique cell surface antigens following episodes of cell-free plasma viremia with concurrent infection of equine dermal (ED) cells with EIAV (McGuire fever, thrombocytopenia, and anemia. Clinical episodes and Crawford, 1978) and serum antibodies to the EIAV occur over the first year of infection with each episode Env glycoproteins Perryman et al. , being associated with an antigenically distinct virus 1990) indicated that antibody dependent cellular cytotoxisolate as defined by virus neutralizing antibody assays icity (ADCC) may play a role in EIAV control. However, (Kono et al., 1973) and the control of the initial viremic two papers have been published on ADCC in horses episode is mediated by lymphocyte responses as indiinfected with EIAV with conflicting results. A lack of cated by the inability of combined immunodeficient Ara-ADCC activity was originally reported (Fujimiya et al. , bian foals to terminate viremia .
1979) followed by a second report that detected ADCC Most horses control EIAV and develop a carrier state activity only during the first viremic episode following that also appears to be associated with immunological infection (Gerencer et al., 1989) . Studies from other lenticontrol as indicated by the recrudescence of viremia viral infections have determined that ADCC mediating and disease in carrier horses treated with cyclophosantibodies are present in HIV-infected humans (Kenealy phamide (Kono et al., 1976) or dexamethasone (Kono et al., 1987; Koup et al., 1989; Tanneau et al., 1990; Nixon et al., 1976; Tumas et al., 1994b) . Following infection of et al., 1992) , HIV-infected chimpanzees (Belo et al., 1991) , horses with EIAV, neutralizing antibodies (Kono, 1968;  SIV-infected macaques (Ohkawa et al., 1995) , and sheep O' Rourke et al., 1989) , complement-fixing antibodies infected with maedi-visna (Tuboly et al., 1991) . ADCC (Kono et al., 1966) , complement-inhibiting antibodies mediating antibodies predominantly recognize the viral (McGuire et al., 1971) , and cytotoxic T lymphocytes Env glycoproteins, surface unit (SU), and transmembrane have been identified. The im-(TM) (Kenealy et al., 1987; Koup et al., 1989 ; Tanneau mune mechanism responsible for the control of viremia et al., 1990) in HIV-infected humans, and the epitopes has not been identified, but passive transfer of heatrecognized are in the conserved regions of the SU and inactivated plasma from carrier horses given prior to TM (Nixon et al., 1992) . infection resulted in decreased clinical illness and an
The identification of immune mechanisms which can function in the face of continually changing viral protein epitopes will increase the understanding of lentivirus/ the viral proteins expressed on the surface of EIAV-inml of growth medium, and incubated in a shaking incubator (37Њ, 200 rpm) for 2 hr. This maximized the reexpresfected equine kidney (EK) cells and to analyze different IgG isotype antibodies binding to these cell surface-exsion of cell surface antigens following trypsinization, while minimizing cell death. Cells were labeled for flow posed viral proteins for their ability to mediate ADCC activity.
cytometry Cr. Normal and 5% calf serum.
EHV-1-infected EK cells at the same passage as the EK cells were infected with 1 m.o.i. of EIAV-WSU5 in a EIAV-infected EK cells were used as negative and posismall amount of medium and incubated at 37Њ overnight.
tive controls, respectively. Target EK cells were washed Virus was removed the next day and fresh medium once in the flask with MEM without serum, lifted with added. Cells were not used for any experiments until ATV, and washed three times with MEM plus 5% BCS in §6 days postinfection because live-cell flow cytometry 50-ml conical centrifuge tubes. Labeled EK cells were experiments indicated this was the first day of maximal resuspended in assay medium (RPMI 1640 containing surface antigen expression of EIAV proteins. EK cells 20 mM HEPES, 1.75 g/L sodium bicarbonate, and 10% were infected with 0.17 m.o.i. of EHV-1. Viruses were FCS) at 2.66 1 10 5 cells/ml and 75 ml was added to each added to 150-cm 2 flasks in 10 ml of medium and cells assay well. were used 20 hr later.
Macrophage cultures were started from heparinized ADCC assays blood collected from normal, uninfected adult horses. Peripheral blood mononuclear cells (PBMCs) were ob-PBMC and polymorphonuclear cells (PMN) isolated tained using Histopaque 1077 (Sigma Chemical Co., St.
from normal, uninfected adult horses were used as efLouis, MO) as described (Wyatt et al., 1988) and macrofector cells in all ADCC assays. PBMC and PMN were phages were isolated (Freundlich and Avdalovic, 1983;  isolated from whole blood and red blood cells were lysed Maury, 1994) . Macrophages were maintained as deusing 0.87% Tris-ammonium chloride, pH 7.2 (Wyatt et scribed (Maury, 1994) and infected with 1 m.o.i. of EIAVal., 1988) . Effector cells were resuspended in assay me-WSU5, as done with EK cells. The macrophage cultures dium and the viability was determined using trypan blue were characterized by morphology and the ability of dye exclusion. Replicates of six with effector to target ú93% of the cells to phagocytize latex beads (Tumas cell ratios of 50:1 or 100:1 were incubated for 8 or 17 hr, et al., 1994a) . Live-cell flow cytometry determined that and 50% of the supernatant was used to determine 51 Cr maximal surface antigen expression occurred at 4 days release in a b-plate reader (Wallac, Gaithersburg, MD). postinfection and subsequent experiments using macroThe formula used to determine SE of the percentage of phages were done at this time.
specific lysis took into account the variability occurring in both the test and the control wells (Siliciano et al., Fluorescent flow cytometry 1985) . ADCC assays using macrophages as target cells were done in a similar manner except that experimental Normal EK cells, EIAV-infected EK cells, and EHV-1-infected EK cells were lifted from 150-cm 2 flasks with 4 and control wells were done in replicates of three. Spontaneous release defined as the mean of wells containing ml ATV, placed in 50-ml conical centrifuge tubes with 15 EK cells (Fig. 2) . Titers were maximal within 1 month postinfection and remained at near maximal levels over the 2-year observation period. Serum samples from a third horse, H507, had titers ranging from 2100 to 2500 between 1.5 and 3.5 years postinfection. Following detection of serum antibodies binding cell surface EIAV Env glycoproteins, serum samples were tested for ADCC activity.
ADCC activity of EIAV serum antibodies
An ADCC assay was developed and several variables were tested including serum dilution, incubation time, target to effector cell ratios, and the effect of preincubation of serum antibodies with effector or target cells. At a serum dilution of 1:30, no ADCC activity was detected lymphocytes can also mediate ADCC (Stokes and Wardley, 1988) . Altering the incubation period of the assay, the effector to target cell ratio, and the serum dilution target and effector cells in the absence of serum or did not result in the detection of ADCC activity. Preincuequine IgG was reduced by using macrophage culture bation of serum with target or effector cells did not result medium (DMEM supplemented with 1.75 g/L sodium biin specific lysis of targets nor were prearmed effector carbonate, 20 mM HEPES, 15% horse serum, and 15% cells detected. To verify that the effector cells could medifetal calf serum).
ate ADCC of EK cell targets, a control assay was developed using an equine herpes virus, EHV-1 (Stokes and Wardley, 1988) . RESULTS
EHV-1 control ADCC assay Antibody responses to EIAV Env glycoproteins on the surface of EK cells
Live-cell flow cytometry was used to demonstrate the presence of unique cell surface antigens following infecLive-cell flow cytometry was used to determine if infected tion of EK cells by EHV-1 and serum antibodies to these EK cells expressed EIAV-WSU5 antigens on their surface as reported for ED cells infected with the prototype strain of EIAV (McGuire and Crawford, 1978) . EIAV-infected EK cells had surface antigen expression as demonstrated by a significant increase in mean peak channel fluorescence over uninfected EK cells (Fig. 1) when reacted with serum collected 1 year post-EIAV-WSU5 infection, but not when reacted with preinfection serum. Uninfected EK cells did not react with either serum. Live-cell flow cytometry using EK cells infected with recombinant vaccinia virus expressing the EIAV Env proteins , with EIAV Gag proteins plus the protease, or with no EIAV proteins (McGuire et al., 1994b) determined that only EIAV Env proteins were expressed on the surface of EK cells. The serum used had antibodies to the EIAV Gag proteins detected by agar gel immunodiffusion. sary for 50% reduction in signals using EIAV-WSU5 infected equine IgG(T) polyclonal serum (Bethyl Laboratories, Inc., Montgomery, TX). A standard curve made with purified IgG spiked with serial dilutions of IgG(T) was used to quantitate the amount of IgG(T) in fractions from the DEAE column. All IgG fractions had less than 0.05% contaminating IgG(T) and still reacted with the Env proteins expressed on the surface of EIAV-WSU5-infected EK cells by live cell flow cytometry.
Purified IgG fractions from EIAV-WSU5-infected horses were tested for ADCC activity and no killing was detected using dilutions of 1:30, 1:300, and 1:3000 of 20 mg/ml IgG. Serum and purified IgG antibodies from three horses infected with the EIAV-Wyo strain were examined to determine if a more virulent virus isolate would induce IgG antibodies mediating ADCC activity. Despite reactivity to EIAV Env glycoproteins expressed on the surface of infected cells, no killing was detected in these assays using whole serum or purified IgG.
ADCC assays using EIAV-infected equine peripheral blood-derived macrophages
To ensure that the lack of ADCC activity in previous macrophage (Sellon et al., 1992) . Peripheral blood mononuclear cells were purified and infected with EIAV. Macrophages had detectable EIAV cell surface antigen exantigens following EHV-1 vaccination of horses. Serum pression by live-cell flow cytometry using polyclonal from six normal horses and three EIAV-infected horses, horse serum antibodies directly conjugated to FITC (Fig. all vaccinated against EHV-1, had antibodies to the sur-4). A twofold increase in peak channel fluorescence was face of EHV-1-infected cells. These sera were tested at apparent when EIAV-infected macrophages were incua 1:30 dilution against EHV-1-infected EK cells (Stokes bated in the presence of post-EIAV infection serum. Even and Wardley, 1988) and all mediated EHV-1-specific ADCC activity (Fig. 3) , although the specific lysis varied among horses. The absence of ADCC against EIAV-infected EK cells combined with the ability of the same serum samples and effector cells to mediate the lysis of EHV-1-infected EK cells indicated that neither the assay format nor the effector cells were responsible for the lack of killing.
ADCC using highly purified equine IgG
Horse IgG(T) antibodies, a subtype of equine IgG, inhibit complement activation (McGuire et al., 1971) and ADCC activity at even low concentrations (Fujimiya et al., 1979) . The presence of Env protein-specific IgG(T) antibodies in the serum samples of EIAV-infected horses could inhibit ADCC activity. IgG   FIG. 4 . Live-cell flow cytometry to demonstrate the presence of EIAV antigens on the surface of macrophages derived from the peripheral blood.
was purified from serum samples from two EIAV-infected EIAV antigens were detected using IgG from a horse infected with EIAVhorses (McGuire et al., 1979) and an ELISA was used to Contaminating IgG(T) was detected using goat anti-though the fluorescence was less than that on infected ADCC activity against EHV-1-infected EK cells (Stokes and Wardley, 1988 ) made these cells a likely target for EK cells (Fig. 1) , the increase on infected macrophages was reproducible and statistically significant (P õ 0.001) lysis by ADCC. Serum samples were collected from three EIAV inby the Kolomogorov-Smirnov test (Young, 1977 ) when compared to the same serum immunoglobulins incufected horses at various times postinfection. Flow cytometry results demonstrated that horses produced antibody bated with uninfected macrophages or FITC-conjugated normal horse serum immunoglobulins incubated with unto EIAV-infected cell surface epitopes that were detectable for at least the first 3.5 years of infection. ADCC infected or EIAV-infected macrophages.
Infected macrophage targets were labeled with 51 Cr assays using sequential serum samples from these horses resulted in no specific lysis of EIAV-infected EK overnight and incubated with serum and freshly isolated PMN were added. Pre-EIAV infection serum and serum target cells using either PBMC or PMN as effector cells regardless of effector to target cell ratios, length of incufrom three horses infected with EIAV-WSU5 for 1 year were tested for ADCC activity. When no ADCC activity bation time, and serum dilution. Furthermore, the use of highly purified IgG from horses infected with EIAV-WSU5 was detected using whole serum, purified IgG from one horse was tested for ADCC activity and again, no specific or EIAV-Wyo strains resulted in IgG antibody binding to target cells, but no specific lysis using either PBMC or killing was detected.
PMN as effector cells. A control ADCC assay was developed using the same EK target cells, the same effector DISCUSSION cells, and serum samples from the same EIAV-infected horses vaccinated against EHV-1. Specific killing of EHV-ADCC has been described following several lentiviral infections with no clear understanding of its role in con-1-infected target EK cells occurred with no significant killing of uninfected target cells by incubation with both trolling viral burden or immunopathogenic processes. This work was done to define ADCC mediating antibod-PBMC and PMN. These results confirmed that the target cells were not resistant to ADCC and that the effector ies following EIAV infection so that their role could be determined by passive antibody transfer experiments.
cells were functional. The use of peripheral blood-derived macrophages as Previous work characterizing ADCC activity in horses determined that ADCC mediating antibodies could be target cells in these ADCC assays resulted in target cells more closely mimicking the in vivo situation where the induced following immunization of horses with sheep red blood cells (Fujimiya et al., 1979) or EHV-1 (Stokes and macrophage is the infected cell (Sellon et al., 1992) . Initial studies indicated that EIAV-infected macrophages exWardley, 1988). Further, it was demonstrated that affinitypurified equine IgG antibodies mediate ADCC whereas pressed viral antigens on their surface at 2 days postinfection and EIAV antigen density on the surface of inthis activity can be blocked by the presence õ13% affinity-purified equine IgG(T) (Fujimiya et al., 1979) . However, fected cells increased, reaching maximal levels at 4 days postinfection. Incubation of EIAV-infected equine macro-ADCC activity against EIAV-infected ED cells could not be demonstrated. Later, ADCC mediating antibodies phages with IgG antibodies in the presence of PBMC or PMN did not result in detectable ADCC activity. were demonstrated in EIAV-infected horses during the initial viremic episode with specific lysis increasing until While we have demonstrated EIAV antigens on the surface of infected EK cells and peripheral blood-derived 8 days postinfection (Gerencer et al., 1989) . This work used peripheral blood lymphocytes isolated from the macrophages, have reacted these cells with IgG antibody to the exposed EIAV antigens, and have used efsame horses stimulated with phytohemaglutinin without the addition of virus as the target cell population. Befector cells (either PBMC or PMN) shown to work in another ADCC system, no ADCC activity was detected. cause the primary infected cell in vivo is the tissue macrophage (Sellon et al., 1992) and peripheral blood monoThe horses were followed over the course of the infection, from acute disease to the carrier state, without decytes express only low levels of viral proteins (Maury, 1994) , it is unclear what this assay measured.
tecting ADCC mediating antibodies. Although we do not know why IgG antibodies cannot mediate ADCC, it may It was our assumption that ADCC antibodies could be demonstrated in EIAV-infected horse serum by using a be due to the number and the spacing of EIAV Env protein molecules on the target cell or to the antibody isotype more susceptible target cell. EK cells (Montelaro et al., 1982) are used for virus production and cytotoxicity within the IgG fraction. Whatever the explanation, these results indicate that ADCC does not play a role in the assays because of the increased number of susceptible/ permissive cells. In this paper, 72% of the EK cells were control of lentiviral replication seen in EIAV following viremic episodes or during the carrier state. infected with EIAV-WSU5 using live-cell flow cytometry compared with ED cultures where 30% of the cells are infected using fluorescent antibody on fixed cells ACKNOWLEDGMENTS (Klevjer-Anderson et al., 1979) . The increase in the number of EK cells expressing EIAV surface antigen recog-USDA Animal Health Formula Funds Grants WNV-00109 and WNVMontelaro, R. C., Lohrey, N., Parekh, B., Blakeney, E. W., and Issel, C. J. (1982) . Isolation and comparative biochemical properties of the major 00116, and NIH Biotechnology Training Grant 5 T32 GM08336.
internal polypeptides of equine infectious anemia virus. J. Virol. 42, 1029-1038.
